AI assistant
BIO-TECHNE Corp — Director's Dealing 2020
Nov 10, 2020
30718_dirs_2020-11-10_fdd4dac8-9b44-40fc-ae30-ec522853b489.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-11-06
Reporting Person: HIGGINS JOHN L (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-06 | Common Stock | M | 5000.00 | $70.35 | Acquired | 9412.00 | Direct |
| 2020-11-06 | Common Stock | S | 1450.00 | $298.9765 | Disposed | 7962.00 | Direct |
| 2020-11-06 | Common Stock | S | 450.00 | $299.8392 | Disposed | 7512.00 | Direct |
| 2020-11-06 | Common Stock | S | 3100.00 | $301.0647 | Disposed | 4412.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-06 | Stock Option (Right to Buy) | $70.35 | M | 5000.00 | Disposed | 2021-10-26 | Common Stock (5000.00) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $201.64 | 2029-10-24 | Common Stock (2011.00) | 2011.00 | Direct |
| Stock Option (Right to Buy) | $179.84 | 2028-10-25 | Common Stock (1898.00) | 1898.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2027-10-27 | Common Stock (3125.00) | 3125.00 | Direct |
| Stock Option (Right to Buy) | $101.19 | 2026-10-26 | Common Stock (3985.00) | 3985.00 | Direct |
| Stock Option (Right to Buy) | $87.34 | 2025-10-28 | Common Stock (4260.00) | 4260.00 | Direct |
| Stock Option (Right to Buy) | $91.78 | 2024-10-30 | Common Stock (4000.00) | 4000.00 | Direct |
| Stock Option (Right to Buy) | $87.39 | 2023-10-30 | Common Stock (4000.00) | 4000.00 | Direct |
| Stock Option (Right to Buy) | $66.90 | 2022-10-24 | Common Stock (5000.00) | 5000.00 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.5100 to $299.2800, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.6050 to $300.4491, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.9950 to $301.0647, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.